Merck & Co.
MRK· Manufacturing· Fiscal year ends in December
Robert M. Davis is the CEO of Merck & Co. and was paid $20.8M in FY2025 (Dec), down 10%.
Executives5
See all- 1Robert M. DavisChairman, Chief Executive Officer and PresidentFY2025
- 2Dean Li, M.D., Ph.D.Executive Vice President and President, Merck Research LaboratoriesFY2025
- 3Caroline LitchfieldExecutive Vice President and Chief Financial OfficerFY2025
- 4Jennifer ZacharyExecutive Vice President and General CounselFY2025
- 5Sanat ChattopadhyayExecutive Vice President and President, Merck Manufacturing DivisionFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allMerck & Co. paid its 5 named executives $48.5M in total in FY2025 (Dec). CEO Robert M. Davis was paid $20.8M of that.
| Name | |||
|---|---|---|---|
| Robert M. DavisChairman, Chief Executive Officer and President | |||
| Dean Li, M.D., Ph.D.Executive Vice President and President, Merck Research Laboratories | |||
| Caroline LitchfieldExecutive Vice President and Chief Financial Officer | |||
| Jennifer ZacharyExecutive Vice President and General Counsel | |||
| Sanat ChattopadhyayExecutive Vice President and President, Merck Manufacturing Division |
of each named executive, from the Summary Compensation Table of each proxy.
Peers12
See allThe FY2025 (Dec) proxy of Merck & Co. names 12 peer companies for pay. Among Merck & Co. and these peers, CEO pay was the lowest of 7 and total shareholder return was 4th highest of 7.
7th highest of 7in Merck & Co. and its pay peers, FY2025 (Dec) by CEO pay:
4th highest of 7in Merck & Co. and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board7
See all- Robert M. Davis ManagementChair · 4 yr on the boardNot independent—Paid as an executive
- Mary Ellen CoeDirector · 6 yr on the boardIndependentCompensation and Management Development, Research—Paid as an executive
- Risa J. Lavizzo-Mourey, M.D.Director · 5 yr on the boardIndependentCompensation and Management Development, Research—Paid as an executive
- Stephen L. Mayo, Ph.D.Director · 4 yr on the boardIndependentAudit, Research—Paid as an executive
- Douglas M. Baker, Jr.Director · 3 yr on the boardIndependentAudit, Research—Paid as an executive
- Surendralal L. KarsanbhaiDirector · 0 yr on the boardIndependentAudit, Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings24
See all| Current report | 8-K | Oct 13, 2026 | — |
| Current report | 8-K | May 28, 2026 | — |
| Proxy statement | DEF 14A | Apr 8, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Current report | 8-K | May 29, 2025 | — |
| Proxy statement | DEF 14A | Apr 9, 2025 | FY2024 |
